LAVA Therapeutics Announces $83 million Series C Financing to Advance Novel Immuno-Oncology Programs

by Ysios Capital

LAVA Therapeutics, a biotech company pioneering the development of bispecific antibodies to engage gamma-delta T cells for cancer therapies, today announced the closing of an oversubscribed $83 millio...

Read more

ProteoDesign announces new Investment led by Ysios Capital and rebrands as Splice Bio

by Ysios Capital

Splice Bio, a biotech company based on technology developed in the Muir Lab at Princeton University, announced today a new investment into the Company led by Ysios Capital and joined by Asabys Partner...

Read more

Cancer Research. The CNIO creates a collaborative platform to streamline brain metastasis research

by CNIO - Centro Nacional de Investigaciones Oncológicas

Science is collaborative by nature, since scientific knowledge only advances, step by step, through combined efforts and findings. Nevertheless, there is often a lack of communication regarding the mo...

Read more

Droplite opens seed round of 600.000€ to accelerate the manufacturing development of its smart medical diagnostics device

by GENESIS Biomed

Drop​lite,a spinoff of the Institute of Photonics Ciences (ICFO), located in the vibrant Parc Cientific de Barcelona (PCB), has recently started the industrial design and manufacturing development o...

Read more

Flomics COVID-19 NGS platform

by Flomics Biotech SL

Flomics has joined forces with international biotech partners, specialized in Next Generation Sequencing tests, to develop a cloud-based data analysis solution for COVID19 detection and research.

Read more

A new platform for the diagnosis of autoimmune encephalitis receives funding from the ERC Proof of Concept grants

by Hospital Universitari de Bellvitge

Dr. Antonella Consiglio's group will receive 150,000 euros for an 18-month project. The project aims to develop a stem cell-based diagnostic method for autoimmune encephalitis detection.

Read more

COVID-19 AND CANCER: Supporting oncologists by providing free OncoKDM access

by OncoDNA

The COVID-19 situation has a major impact on oncological clinical routine practice with collateral effects on patient’s life, OncoDNA offers to labs and oncologists a free access to its Clinical Dec...

Read more

Sant Joan de Déu seeks young patients and caregivers to create the first pediatric expert patient database

by Fundació Sant Joan de Déu

​People registered on this platform will help to include the vision of patients in the process of developing clinical trials in pediatrics.

Read more

Rounds of funding, grants, pipeline advances, appointments and discoveries in leukemia

by Biocat

Rounds at Ability, Elma and Vytrus and “la Caixa” grants, among the top headlines in September

Read more

Enantia develops an innovative Cannabinoids Cocrystal Platform

by Parc Científic de Barcelona

Enantia, a company with headquarters in the Barcelona Science Park and specialised in R&D process chemistry, solid form development and medicinal chemistry, has again succeeded in applying cocrystalli...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

El GTM analiza los diferentes tipos de v...

by Revista Genética Médica

El Grupo de Trabajo Multidisciplinar, que asesora al Ministerio de Cie...

Photos Stream